Jaguar Health, Inc. (JAGX) Net margin 2016–2025
Jaguar Health, Inc. (JAGX) net profit margin by fiscal year — reported net income divided by reported revenue.
-465.4%FY2025 · since FY2016: -10410.9% → -465.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -465.4% | -136.1 pp |
| FY2024 | -329.3% | -328.9 pp |
| FY2023 | -0.4% | -0.0 pp |
| FY2022 | -0.4% | +0.8 pp |
| FY2021 | -1.2% | +359.0 pp |
| FY2020 | -360.2% | +307.1 pp |
| FY2019 | -667.3% | +60.6 pp |
| FY2018 | -727.9% | -224.2 pp |
| FY2017 | -503.7% | +9907.1 pp |
| FY2016 | -10410.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Total liabilitiesJAGX Shareholders’ equityJAGX overview →